CD8A and neoplasm: ,45 To interrogate the phenotype of circulating and tumor-infiltrating CD8+ T cells in patients with BrMs, we performed high-parameter flow cytometry on patient-matched tumor-infiltrating and circulating CD8+ T cells (Figure S2A).